GET IN TOUCH

+49 8141 150 55 0

Brown Sneakers siGRP 2V Module
for production of the ​[​F-18]siPSMA and [F-18]SiFAlin-TATE and new upcoming SiFA-Tracers we have designed a dedicated GRP Module that provide considerable advantages.
SEE MORE
siGRP Module
Beige  Skate Shoes THERANOSTICS PLUS Module
GRP 3V
GRP 3V is the mid-size configuration of our off the shelf modules. In addition to the tracers that can be produced with GRP-2V, this model can also be used for Y-90-, Cu-64- or C-11-tracers, and F-18 FDG, to mention only a few.
SEE MORE

PSMA-Inhibitors

Since February 2019, Scintomics GmbH and its subsidiaries have an exclusive sublicense on European Patent EP 1 289 571 B1 which is in force in Germany, Great Britain, France, Italy and Spain. This Exclusive License also comprises Australian Patent AU2001/277488B2

This sublicense covers DOTAGA-conjugated bioactive compounds and their radiometalated products that bind to the following target structures:

PSMA (also known as glutamate carboxypeptidase II)
Somatostatin receptors
Chemokine receptors (i.e. CXCR4)
Bombesin receptors (BB1-BB3)
Folate receptors
Heat shock proteins
Fibroblast-activating protein (FAP)

Slide Imaging RADIOLIGAND THERAPY

Subscribe to our newsletter

Get all the latest information on events, sales and
offers. Sign up for newsletter:



    Our mission

    Our mission is to develop new and powerful agents for cancer imaging and therapy that improve treatment decisions and the clinical management of cancer patients.